InsightfulValue
← Home

Novo Nordisk
Novo Nordisk

Pharma / Pharmaceuticals and Healthcare


📢 Press Releases

Date Press release
2025-05-22 08:00:00 New Novo Nordisk Initiatives Support Patient Access To Authentic, Fda-approved Wegovy® As Federal Ban On Mass Compounding Of \"semaglutide\" Takes Effect
With all doses of fda-approved wegovy® fully available nationwide, it is illegal under us compounding laws to make or sell knockoff ’semaglutide’ drugs, with rare exceptions new, one-time $199 first-month offer for wegovy® available through june 30, 2025; offer designed to help new self-paying patients previously prescribed unapproved ’semaglutide’ start on fda-approved wegovy® ’choose the real thing’ campaign launching to raise awareness about the dangers of knockoff ’semaglutide’ novo nordisk intensifies legal actions aimed at protecting patients from risks and dangers associated with compounded ’semaglutide’ drugs and their foreign illicit active ingredients plainsboro, n.j. , may 22, 2025 /prnewswire/ -- today, as the us food and drug administration (fda) grace period for mass compounding of ’semaglutide’ expires, novo nordisk announced a series of initiatives to further support patient access to authentic, fda-approved wegovy® (semaglutide) injection 2.4 mg.
2025-05-16 07:19:00 Novo Nordisk A/s: Lars Fruergaard JØrgensen To Step Down As Ceo Of Novo Nordisk
BagsvÆrd, denmark, 16 may 2025 – novo nordisk today announced changes to its executive leadership and board of directors. as per mutual agreement with the novo nordisk board, lars fruergaard jØrgensen will step down from his role as ceo of novo nordisk.
2025-05-12 02:01:00 Novo Nordisk A/s: Once-weekly Sogroya® (somapacitan) Is An Efficacious And Well-tolerated Long-acting Growth Hormone In Children With Growth Disorders: Results From Real8 Phase 3 Basket Study Presented At The Joint Congress Of Espe And Ese
BagsvÆrd, denmark, 12 may 2025 – novo nordisk today presented data from the phase 3 real8 basket study, which showed that once-weekly sogroya® (somapacitan) was non-inferior to the once-daily growth hormone norditropin® (somatropin) in improving yearly growth rate (as measured by height velocity [hv] at week 52) in pre-pubertal children born small for gestational age (sga)1, or with noonan syndrome (ns)2, or with idiopathic short stature (iss)3. in addition, superiority was achieved for once-weekly sogroya® versus daily growth hormone in children with ns2, as well as compared to lower doses of daily growth hormone in children born sga1.
2025-05-09 07:22:00 Novo Nordisk A/s: Trading In Novo Nordisk Shares By Board Members, Executives And Associated Persons
BagsvÆrd, denmark, 9 may 2025 — this company announcement discloses the data of the transaction(s) made in novo nordisk shares by the company’s board members, executives and their associated persons in accordance with article 19 of regulation no. 596/2014 on market abuse.
2025-05-07 01:30:00 Novo Nordisk’s Sales Increased By 19% In Danish Kroner And By 18% At Constant Exchange Rates To Dkk 78.1 Billion In The First Three Months Of 2025
7 may 2025 -  financial report for the period 1 january 2025 to 31 march 2025
2025-05-06 08:00:00 Tm92byBSZX NvdXJjZXMg UmVsZWFzZX MgVXBkYXRl ZCBDb3Jwb3 JhdGUgUHJl c2VudGF0aW 9u
UGVydGgsIH dlc3QgYXVz dHJhbGlhLC BtYXkgMDYs IDIwMjUgKG dsb2JlIG5l d3N3aXJlKS AtLSBub3Zv IHJlc291cm NlcyBjb3Jw LiAobm92by BvciB0aGUg Y29tcGFueS kgKGFzeDog bnZvKSAodH N4OiBudm8p IChvdGNxYj ogbnNycGYp IGlzIHBsZW FzZWQgdG8g YW5ub3VuY2 UgdGhlIHJl bGVhc2Ugb2 YgaXRzIHVw ZGF0ZWQgY2 9ycG9yYXRl IHByZXNlbn RhdGlvbiwg bm93IGF2YW lsYWJsZSBv biB0aGUgY2 9tcGFueeKA mXMgd2Vic2 l0ZS4gdGhl IG5ldyBwcm VzZW50YXRp b24gb3V0bG luZXMgbm92 b+KAmXMgc3 RyYXRlZ2lj IHByaW9yaX RpZXMsIGV4 cGxvcmF0aW 9uIHJlc3Vs dHMsIHByb2 plY3QgYWR2 YW5jZW1lbn RzLCBhbmQg bmVhci10ZX JtIGNhdGFs eXN0cy4=
2025-04-09 15:45:00 Tm92byBSZX NvdXJjZXMg Q29ycC4gVW 52ZWlscyBO ZXcgQ29ycG 9yYXRlIFBy ZXNlbnRhdG lvbiBGb3Ig SW52ZXN0b3 Jz
UGVydGgsIH dlc3Rlcm4g YXVzdHJhbG lhLCBhcHJp bCAwOSwgMj AyNSAoZ2xv YmUgbmV3c3 dpcmUpIC0t IG5vdm8gcm Vzb3VyY2Vz IGNvcnAuIC hub3ZvIG9y IHRoZSBjb2 1wYW55KSAo YXN4OiBudm 8pICh0c3g6 IG52bykgKG 90Y3FiOiBu c3JwZikgaX MgcGxlYXNl ZCB0byBwcm 92aWRlIHRo ZSBsYXVuY2 ggb2YgaXRz IGFwcmlsIG NvcnBvcmF0 ZSBwcmVzZW 50YXRpb24s IGFpbWVkIG F0IHByb3Zp ZGluZyBpbn Zlc3RvcnMg d2l0aCBhIG NvbXByZWhl bnNpdmUgYW 5kIHVwLXRv LWRhdGUgb3 ZlcnZpZXcg b2YgdGhlIG NvbXBhbnni gJlzIGdyb3 d0aCBzdHJh dGVneSBhbm Qga2V5IHBy b2plY3RzIH Rocm91Z2hv dXQgaXRzIG F1c3RyYWxp YW4gZm9jdX NlZCBnb2xk IGV4cGxvcm F0aW9uIHBv cnRmb2xpby 4=
2025-04-03 02:00:00 Tm92byBOb3 JkaXNrIEFu bm91bmNlcy BDaGFuZ2Vz IEluIEV4ZW N1dGl2ZSBN YW5hZ2VtZW 50
QmFnc3bDhn JkLCBkZW5t YXJrLCAzIG FwcmlsIDIw MjUg4oCTIG 5vdm8gbm9y ZGlzayB0b2 RheSBhbm5v dW5jZWQgdG hlIGZvbGxv d2luZyBjaG FuZ2VzIGlu IGV4ZWN1dG l2ZSBtYW5h Z2VtZW50Li BhZnRlciBh IGRpc3Rpbm d1aXNoZWQg Y2FyZWVyIG 9mIDI4IHll YXJzIHdpdG ggbm92byBu b3JkaXNrLC BoZXJlb2Yg c2V2ZW4geW VhcnMgYXMg ZXhlY3V0aX ZlIHZpY2Ug cHJlc2lkZW 50IG9mIGNv bW1lcmNpYW wgc3RyYXRl Z3kgJiBjb3 Jwb3JhdGUg YWZmYWlycy wgY2FtaWxs YSBzeWx2ZX N0IGhhcyBk ZWNpZGVkIH RvIGxlYXZl IHRoZSBjb2 1wYW55Lg==
2025-03-29 14:33:00 Tm92byBOb3 JkaXNrIEEv czogUnliZW xzdXPCriAo b3JhbCBTZW 1hZ2x1dGlk ZSAxNCBNZy kgRGVtb25z dHJhdGVzIF N1cGVyaW9y IFJlZHVjdG lvbiBJbiBD YXJkaW92YX NjdWxhciBF dmVudHMgSW 4gVGhlIFNv dWwgVHJpYW wgQXQgQWNj IDIwMjU=
QmFnc3bDhn JkLCBkZW5t YXJrLCAyOS BtYXJjaCAy MDI1IOKAky Bub3ZvIG5v cmRpc2sgdG 9kYXkgcHJl c2VudGVkIH RoZSBmdWxs IHJlc3VsdH MgZnJvbSB0 aGUgc291bC BjYXJkaW92 YXNjdWxhci BvdXRjb21l cyB0cmlhbC wgZGVtb25z dHJhdGluZy B0aGF0IHJ5 YmVsc3Vzwq 4gKG9yYWwg c2VtYWdsdX RpZGUpIHNp Z25pZmljYW 50bHkgcmVk dWNlZCB0aG UgcmlzayBv ZiBtYWpvci BhZHZlcnNl IGNhcmRpb3 Zhc2N1bGFy IGV2ZW50cy BpbiBhZHVs dHMgd2l0aC B0eXBlIDIg ZGlhYmV0ZX MgYW5kIGNh cmRpb3Zhc2 N1bGFyIGRp c2Vhc2UgKG N2ZCkgYW5k L29yIGNocm 9uaWMga2lk bmV5IGRpc2 Vhc2UgKGNr ZCkxLiB0aG VzZSBuZXcg ZGF0YSBmcm 9tIHRoZSBw aGFzZSAzYi B0cmlhbCB3 ZXJlIGZlYX R1cmVkIGR1 cmluZyBhIG xhdGUtYnJl YWtpbmcgY2 xpbmljYWwg dHJpYWwgc2 Vzc2lvbiBh dCB0aGUgYW 1lcmljYW4g Y29sbGVnZS BvZiBjYXJk aW9sb2d54o CZcyAoYWNj KSBhbm51YW wgc2NpZW50 aWZpYyBzZX NzaW9uIGFu ZCBleHBvIG luIGNoaWNh Z28sIHVzIG FuZCBzaW11 bHRhbmVvdX NseSBwdWJs aXNoZWQgdG 9kYXkgaW4g bmV3IGVuZ2 xhbmQgam91 cm5hbCBvZi BtZWRpY2lu ZSAyLg==
2025-03-28 09:11:00 Q2hhbmdlIE luIEF1c3Ry YWxpYW4gU2 hhcmVob2xk ZXIgUmVnaX N0cnkgU2Vy dmljZXM=
UGVydGgsIG F1c3RyYWxp YSwgbWFyY2 ggMjgsIDIw MjUgKGdsb2 JlIG5ld3N3 aXJlKSAtLS Bub3ZvIHJl c291cmNlcy Bjb3JwLiAo bm92byBvci B0aGUgY29t cGFueSkgKG FzeDogbnZv KSAodHN4Oi Budm8pIChv dGNxeDogbn NycGYpIGFk dmlzZXMgdG hhdCBhcyBv ZiBtb25kYX ksIDMxIG1h cmNoIDIwMj UsIG5vdm8g aGFzIGNoYW 5nZWQgaXRz IHByb3ZpZG VyIGZvciBz aGFyZWhvbG RlciByZWdp c3RyeSBzZX J2aWNlcyBm cm9tIG11Zm cgcGVuc2lv biAmIG1hcm tldCBzZXJ2 aWNlc8KgdG 8gYXV0b21p YyBwdHkgbH RkLg==
2025-03-27 11:17:00 UmVzb2x1dG lvbnMgRnJv bSBUaGUgQW 5udWFsIEdl bmVyYWwgTW VldGluZyBP ZiBOb3ZvIE 5vcmRpc2sg QS9z
QmFnc3bDhn JkLCBkZW5t YXJrLCAyNy BtYXJjaCAy MDI1wqAtIH RvZGF5LCBu b3ZvIG5vcm Rpc2sgYS9z IGhlbGQgaX RzIGFubnVh bCBnZW5lcm FsIG1lZXRp bmcuIGF0IH RoZSBhbm51 YWwgZ2VuZX JhbCBtZWV0 aW5nLCBoZW xnZSBsdW5k LCBjaGFpci BvZiB0aGUg Ym9hcmQgb2 YgZGlyZWN0 b3JzIGNvbW 11bmljYXRl ZDog4oCcMj AyNCB3YXMg YW5vdGhlci B5ZWFyIG9m IHNpZ25pZm ljYW50IGdy b3d0aCBmb3 Igbm92byBu b3JkaXNrLC BjaGFyYWN0 ZXJpc2VkIG J5IGNvbnRp bnVlZCBpbm 5vdmF0aW9u LCBjYXBhY2 l0eSBleHBh bnNpb25zIG FuZCBjb21t ZXJjaWFsIG V4ZWN1dGlv bi4=
2025-03-25 16:30:00 Q2xhc3MgQW N0aW9uIEZp bGVkIEFnYW luc3QgTm92 byBOb3JkaX NrIEEvcyAo bnZvKSAtIE 1hcmNoIDI1 LCAyMDI1IE RlYWRsaW5l IFRvIEpvaW 4gLSBDb250 YWN0IExldm kgJiBLb3Jz aW5za3k=
TmV3IHlvcm ssIG55IC8g YWNjZXNzIG 5ld3N3aXJl IC8gbWFyY2 ggMjUsIDIw MjUgLyBpZi B5b3Ugc3Vm ZmVyZWQgYS Bsb3NzIG9u IHlvdXIgbm 92byBub3Jk aXNrIGEvcy AobnlzZTpu dm8pIGludm VzdG1lbnQg YW5kIHdhbn QgdG8gbGVh cm4gYWJvdX QgYSBwb3Rl bnRpYWwgcm Vjb3Zlcnkg dW5kZXIgdG hlIGZlZGVy YWwgc2VjdX JpdGllcyBs YXdzLCBmb2 xsb3cgdGhl IGxpbmsgYm Vsb3cgZm9y IG1vcmUgaW 5mb3JtYXRp b246IGh0dH BzOi8vemxr LmNvbS9wc2 xyYS0xL25v dm8tbm9yZG lzay1hLXMt bGF3c3VpdC 1zdWJtaXNz aW9uLWZvcm 0/cHJpZD0x Mzg2NDUmd2 lyZT0xIG9y IGNvbnRhY3 Qgam9zZXBo IGUuIGxldm ksIGVzcS4=
2025-03-25 13:30:00 SW52ZXN0b3 JzIFdobyBM b3N0IE1vbm V5IE9uIE5v dm8gTm9yZG lzayBBL3Mg KG52bykgU2 hvdWxkIENv bnRhY3QgTG V2aSAmIEtv cnNpbnNreS BBYm91dCBQ ZW5kaW5nIE NsYXNzIEFj dGlvbiAtIE 52bw==
TmV3IHlvcm ssIG55IC8g YWNjZXNzIG 5ld3N3aXJl IC8gbWFyY2 ggMjUsIDIw MjUgLyBpZi B5b3Ugc3Vm ZmVyZWQgYS Bsb3NzIG9u IHlvdXIgbm 92byBub3Jk aXNrIGEvcy AobnlzZTpu dm8pIGludm VzdG1lbnQg YW5kIHdhbn QgdG8gbGVh cm4gYWJvdX QgYSBwb3Rl bnRpYWwgcm Vjb3Zlcnkg dW5kZXIgdG hlIGZlZGVy YWwgc2VjdX JpdGllcyBs YXdzLCBmb2 xsb3cgdGhl IGxpbmsgYm Vsb3cgZm9y IG1vcmUgaW 5mb3JtYXRp b246IGh0dH BzOi8vemxr LmNvbS9wc2 xyYS0xL25v dm8tbm9yZG lzay1hLXMt bGF3c3VpdC 1zdWJtaXNz aW9uLWZvcm 0/cHJpZD0x Mzg2MDQmd2 lyZT0xIG9y IGNvbnRhY3 Qgam9zZXBo IGUuIGxldm ksIGVzcS4=
2025-03-25 11:15:00 U2hhcmVob2 xkZXJzIFRo YXQgTG9zdC BNb25leSBP biBOb3ZvIE 5vcmRpc2sg QS9zIChudm 8pIFNob3Vs ZCBDb250YW N0IExldmkg JiBLb3JzaW 5za3kgQWJv dXQgUGVuZG luZyBDbGFz cyBBY3Rpb2 4gLSBOdm8=
TmV3IHlvcm ssIG55IC8g YWNjZXNzIG 5ld3N3aXJl IC8gbWFyY2 ggMjUsIDIw MjUgLyBpZi B5b3Ugc3Vm ZmVyZWQgYS Bsb3NzIG9u IHlvdXIgbm 92byBub3Jk aXNrIGEvcy AobnlzZTpu dm8pIGludm VzdG1lbnQg YW5kIHdhbn QgdG8gbGVh cm4gYWJvdX QgYSBwb3Rl bnRpYWwgcm Vjb3Zlcnkg dW5kZXIgdG hlIGZlZGVy YWwgc2VjdX JpdGllcyBs YXdzLCBmb2 xsb3cgdGhl IGxpbmsgYm Vsb3cgZm9y IG1vcmUgaW 5mb3JtYXRp b246IGh0dH BzOi8vemxr LmNvbS9wc2 xyYS0xL25v dm8tbm9yZG lzay1hLXMt bGF3c3VpdC 1zdWJtaXNz aW9uLWZvcm 0/cHJpZD0x Mzg1NzMmd2 lyZT0xIG9y IGNvbnRhY3 Qgam9zZXBo IGUuIGxldm ksIGVzcS4=
2025-03-25 11:00:00 TnZvIERlYW RsaW5lIFRv ZGF5OiBSb3 NlbiwgR2xv YmFsIEludm VzdG9yIENv dW5zZWwsIE VuY291cmFn ZXMgTm92by BOb3JkaXNr IEEvcyBJbn Zlc3RvcnMg VG8gU2VjdX JlIENvdW5z ZWwgQmVmb3 JlIEltcG9y dGFudCBNYX JjaCAyNSBE ZWFkbGluZS BJbiBTZWN1 cml0aWVzIE NsYXNzIEFj dGlvbiAtIE 52bw==
TmV3IHlvcm ssIG55IC8g YWNjZXNzIG 5ld3N3aXJl IC8gbWFyY2 ggMjUsIDIw MjUgLyB3aH k6IHJvc2Vu IGxhdyBmaX JtLCBhIGds b2JhbCBpbn Zlc3RvciBy aWdodHMgbG F3IGZpcm0s IHJlbWluZH MgcHVyY2hh c2VycyBvZi BzZWN1cml0 aWVzIG9mIG 5vdm8gbm9y ZGlzayBhL3 MgKG55c2U6 bnZvKSBiZX R3ZWVuIG5v dmVtYmVyID IsIDIwMjIg YW5kIGRlY2 VtYmVyIDE5 LCAyMDI0LC Bib3RoIGRh dGVzIGluY2 x1c2l2ZSAo dGhlIOKAmW NsYXNzIHBl cmlvZOKAmS ksIG9mIHRo ZSBpbXBvcn RhbnQgbWFy Y2ggMjUsID IwMjUgbGVh ZCBwbGFpbn RpZmYgZGVh ZGxpbmUuIH NvIHdoYXQ6 IGlmIHlvdS BwdXJjaGFz ZWQgbm92by Bub3JkaXNr IHNlY3VyaX RpZXMgZHVy aW5nIHRoZS BjbGFzcyBw ZXJpb2QgeW 91IG1heSBi ZSBlbnRpdG xlZCB0byBj b21wZW5zYX Rpb24gd2l0 aG91dCBwYX ltZW50IG9m IGFueSBvdX Qgb2YgcG9j a2V0IGZlZX Mgb3IgY29z dHMgdGhyb3 VnaCBhIGNv bnRpbmdlbm N5IGZlZSBh cnJhbmdlbW VudC4=
Novo Nordisk

📰 Browse additional press releases for Novo Nordisk!

Sign up for free or log in

📘 Claim your free eBook: "The Checklist Value Investor — A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal